Download presentation
Presentation is loading. Please wait.
1
RCGP and Cancer Research UK Workshop
Hallmark Hotel, Leyland Way, Leyland, Preston, PR25 4JX 11th July 2018 Dr Richard Roope RCGP and Cancer Research UK Cancer Clinical Champion Senior Clinical Advisor Cancer Research UK
2
RCGP and Cancer Research UK Workshop
Housekeeping Fire Exits Toilets Mobile phones Questions Certificates Thanks to the team who have set up the day: RCGP and Cancer Research UK Team Hallmark Hotel Staff
3
RCGP and Cancer Research UK Workshop
The Day: The expanding role of Primary Care and Cancer Control Tea and Coffee Implementation of NG12 (recognition and referral of suspected cancer) and vague symptoms Lunch and networking Bowel Cancer Screening North West Project Insights from the National Cancer Diagnosis Audit and Multi-Diagnostic Centre Evaluation Optimal Lung Cancer Pathway Key take home, evaluation and close
4
RCGP and Cancer Research UK Workshop Primary Care and Cancer Control
5
RCGP and Cancer Research UK Workshop Primary Care and Cancer Control
Cancer: why all the interest? Why is early diagnosis important? Past – where were we? Present – where are we? Future – where next? Survivorship End of life care
6
RCGP and Cancer Research UK Workshop
Cancer: why all the interest?
7
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? Causes of death <75 1 Circulatory Disease Cancer Liver Respiratory Other 2 Cancer Other Circulatory Disease Liver Respiratory 3 Circulatory Disease Cancer Respiratory Liver Other 4 Cancer Circulatory Disease Other Respiratory Liver
8
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? Causes of death <75 1 Circulatory Disease Cancer Liver Respiratory Other 2 Cancer Other Circulatory Disease Liver Respiratory 3 Circulatory Disease Cancer Respiratory Liver Other 4 Cancer Circulatory Disease Other Respiratory Liver Which do you think is the correct column? (high to low)
9
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? Causes of death <75 1 Circulatory Disease Cancer Liver Respiratory Other 2 Cancer Other Circulatory Disease Liver Respiratory 3 Circulatory Disease Cancer Respiratory Liver Other 4 Cancer Circulatory Disease Other Respiratory Liver
10
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? (last accessed )
11
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? 37% Last accessed
12
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? (last accessed )
13
RCGP and Cancer Research UK Workshop Cancer – why all the interest
RCGP and Cancer Research UK Workshop Cancer – why all the interest? The Future:
14
RCGP and Cancer Research UK Workshop The perfect storm:
15
RCGP and Cancer Research UK Workshop The perfect storm:
16
RCGP and Cancer Research UK Workshop The Scale of the Challenge:
The perfect storm…
17
RCGP and Cancer Research UK Workshop The Scale of the Challenge:
The perfect storm… Aging population
18
RCGP and Cancer Research UK Workshop Aging Population
Life expectancy UK Higher Income countries (Accessed )
19
RCGP and Cancer Research UK Workshop Aging Population - Centenarians
2013 2063 X Male 2,242 43,689 19.5 Female 12,328 66,359 5.4 TOTAL 14,750 110,048 7.5 last accessed last accessed
20
RCGP and Cancer Research UK Workshop Aging Population - Centenarians
last accessed
21
RCGP and Cancer Research UK Workshop Aging and Cancer
22
RCGP and Cancer Research UK Workshop Aging and Cancer
Male Female Mortality from all cancers last accessed
23
RCGP and Cancer Research UK Workshop Aging and Cancer
Male Female Mortality from all cancers last accessed
24
RCGP and Cancer Research UK Workshop The Scale of the Challenge:
The perfect storm… Aging population Lifestyles less healthy: Smoking Weight Diet Alcohol Exercise Sun exposure
25
RCGP and Cancer Research UK Workshop The Scale of the Challenge:
The perfect storm… Aging population Lifestyles less healthy: Smoking Weight Diet Alcohol Exercise Sun exposure Increasing survival
26
RCGP and Cancer Research UK Workshop The perfect storm:
Numbers of cancers 2013 2030 % increase UK 352,000 424,789 20.7% Global 14.1 million 23.6 million 67.4% last accessed Last accessed
27
RCGP and Cancer Research UK Workshop The Scale of the Challenge:
By the end of 2016, there were 1,000 people in the UK being diagnosed with cancer every day Mistry, M., et al., Cancer incidence in the United Kingdom: projections to the year Br J Cancer, : p
28
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime
29
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime 10 year survival has improved to reach 50%
30
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime 10 year survival has improved to reach 50% – last accessed
31
RCGP and Cancer Research UK Workshop
Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime 10 year survival has improved to reach 50%, but… Cancer survival in the UK still lags behind comparable health economies
32
RCGP and Cancer Research UK Workshop
Hasn’t cancer had its turn?
33
RCGP and Cancer Research UK Workshop
Hasn’t cancer had its turn? Cancer receives what proportion of NHS spend? 2.0% 5.0% 8.0% 11.0% 14.0% Discuss with your neighbour….
34
RCGP and Cancer Research UK Workshop
Hasn’t cancer had its turn? Cancer receives what proportion of NHS spend? 2.0% 5.0% 8.0% 11.0% 14.0% Discuss with your neighbour….
35
RCGP and Cancer Research UK Workshop
168€ 128€ last accessed
36
RCGP and Cancer Research UK Workshop
Why is early diagnosis important?
37
RCGP and Cancer Research UK Workshop
Why is early diagnosis important? (last accessed )
38
RCGP and Cancer Research UK Workshop
Why is early diagnosis important?
39
RCGP and Cancer Research UK Workshop
Why is early diagnosis important? (last accessed )
40
RCGP and Cancer Research UK Workshop
Why is early diagnosis important?
41
RCGP and Cancer Research UK Workshop
Why is early diagnosis important? (last accessed )
42
RCGP and Cancer Research UK Workshop
Why is early diagnosis important?
43
RCGP and Cancer Research UK Workshop
Why is early diagnosis important? (last accessed )
44
RCGP and Cancer Research UK Workshop
Why is early diagnosis important?
45
Proportion of Cases Diagnosed at Each Stage
RCGP and Cancer Research UK Workshop Why is early diagnosis important? Proportion of Cases Diagnosed at Each Stage (last accessed )
46
Proportion of Cases Diagnosed at Each Stage
RCGP and Cancer Research UK Workshop Why is early diagnosis important? Proportion of Cases Diagnosed at Each Stage Stage Shift (last accessed )
47
RCGP and Cancer Research UK Workshop
Minimum increased 5 year survival with 10% increase in stages 1 & 2 Colorectal 4.00% Ovary Breast 3.80% Endometrium 3.70% Prostate 2.40% Melanoma 2.30% Lung 2.00% Kidney Bladder 1.30% NHL 0.20% (last accessed )
48
RCGP and Cancer Research UK Workshop
How are we doing?
49
RCGP and Cancer Research UK Workshop
How did we do?
50
RCGP and Cancer Research UK Workshop
How did we do?
51
RCGP and Cancer Research UK Workshop
How did we do? (last accessed )
52
RCGP and Cancer Research UK Workshop
How did we do? (last accessed )
53
RCGP and Cancer Research UK Workshop
Emergency Diagnosis % Dec-12 21.0% Mar-13 Jun-13 20.8% Sep-13 20.5% Dec-13 20.4% Mar-14 20.3% Jun-14 20.2% Sep-14 Dec-14 Mar-15 20.1% Jun-15 Sep-15 20.0% Dec-15 19.9% Mar-16 Jun-16 19.7% Sep-16 19.8% Dec-16 Mar-17 19.5% Jun-17 19.4% Sep-17 19.2% How have we done? (last accessed )
54
RCGP and Cancer Research UK Workshop
Emergency Diagnosis % Dec-12 21.0% Mar-13 Jun-13 20.8% Sep-13 20.5% Dec-13 20.4% Mar-14 20.3% Jun-14 20.2% Sep-14 Dec-14 Mar-15 20.1% Jun-15 Sep-15 20.0% Dec-15 19.9% Mar-16 Jun-16 19.7% Sep-16 19.8% Dec-16 Mar-17 19.5% Jun-17 19.4% Sep-17 19.2% How have we done? (last accessed )
55
RCGP and Cancer Research UK Workshop
How have we done? Early Stage Diagnosis Sep-13 46% Dec-13 47% Mar-14 48% Jun-14 49% Sep-14 50% Dec-14 Mar-15 51% Jun-15 Sep-15 52% Dec-15 Mar-16 Jun-16 53% Sep-16 Dec-16 (last accessed )
56
RCGP and Cancer Research UK Workshop
How have we done? (last accessed )
57
RCGP and Cancer Research UK Workshop
Variation: Lancashire and South Cumbria NHS Region (last accessed )
58
RCGP and Cancer Research UK Workshop
Variation: Lincolnshire CCGs (last accessed )
59
RCGP and Cancer Research UK Workshop
ONS Press release : “The one-year all-cancer survival index for England increased steadily from 61.2% for patients diagnosed in 2000 to 72.3% in 2015.” (last accessed )
60
RCGP and Cancer Research UK Workshop
ONS Press release : (last accessed )
61
RCGP and Cancer Research UK Workshop
ONS Press release : “The inequality gap in the cancer survival index between the highest and lowest CCG in England has shrunk since 2000.” “As for CCGs, the inequality gap between the highest and lowest STP in England has reduced since 2000, having halved for STPs over this period.” (last accessed )
62
RCGP and Cancer Research UK Workshop
However compared to Europe?
63
RCGP and Cancer Research UK Workshop
However compared to Europe?
64
RCGP and Cancer Research UK Workshop
However compared to Europe?
65
RCGP and Cancer Research UK Workshop
Why do we lag behind other Health Systems?
66
RCGP and Cancer Research UK Workshop
Why do we lag behind other Health Systems? International Cancer Benchmarking Partnership As gatekeepers – the gate needs to be wider Outcomes closely linked to “readiness to act” Patients fear wasting GP time Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? British Journal of Cancer (2013) 108, 292–300. doi: /bjc (last accessed )
67
RCGP and Cancer Research UK Workshop
Gate openers…
68
RCGP and Cancer Research UK Workshop
69
RCGP and Cancer Research UK Workshop
70
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Save thousands more lives Transform patient experience and quality of life Invest now to save later (last accessed )
71
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Save thousands more lives
72
Cancer Control in Primary Care
Cancer Strategy has three core aims: Save thousands more lives - <75 preventable cancers Under 75 mortality rate for cancer considered preventable (last accessed )
73
Cancer Control in Primary Care
Cancer Strategy has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention
74
Cancer Control in Primary Care
Cancer Strategy has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Ambition:
75
Cancer Control in Primary Care
Cancer Strategy has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Ambition: Fall in age-standardised incidence Adult smoking rates to fall to 13% (currently 17.5%)
76
Cancer Control in Primary Care
Smoking prevalence in UK (last accessed )
77
Cancer Control in Primary Care
Smoking prevalence in UK 21% target by 2020 13% target by 2020 Dec-20 (last accessed )
78
Cancer Control in Primary Care
Smoking prevalence in UK 21% target by 2020 13% target by 2020 Dec-20 (last accessed )
79
Cancer Control in Primary Care
Cancer Strategy has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Smoking cessation:
80
Cancer Control in Primary Care
Cancer Strategy has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Smoking cessation: £1 investment leads to a return of (including NHS savings and value of health gains) 2 years £ 5 years £ 10 years £ Lifetime £
81
Cancer Control in Primary Care
Cancer Strategy has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Weight management:
82
Cancer Control in Primary Care
Cancer Strategy has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention (last accessed )
83
Cancer Control in Primary Care
Cancer Strategy has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Weight management: PHE: “Let’s talk about weight”
84
Cancer Control in Primary Care
Weight management: PHE: “Let’s talk about weight” (last accessed )
85
Cancer Control in Primary Care
Prevention – Brown et al (2018)recent update to Parkin et al (2010): Parkin, D. M. et al. The fraction of cancer attributable to lifestyle and environmental factors in the UK in Br. J. Cancer 105, Si–S81 (2011). Brown, K..F. et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in British Journal of Cancer
86
Cancer Control in Primary Care
Prevention – Interactive CRUK risk calculator
87
Cancer Control in Primary Care
Prevention – Interactive CRUK risk calculator
88
Cancer Control in Primary Care
Prevention – WCRF report (last accessed )
89
Cancer Control in Primary Care
Prevention – WCRF report – interactive cancer risk matrix (last accessed )
90
Cancer Control in Primary Care
Prevention – WCRF report (last accessed )
91
Cancer Control in Primary Care
Prevention – WCRF report – 10 recommendations (last accessed )
92
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Save thousands more lives: Spearhead a radical upgrade in prevention Drive a national ambition to achieve earlier diagnosis, and with it stage shift
93
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Save thousands more lives: Spearhead a radical upgrade in prevention Drive a national ambition to achieve earlier diagnosis, and with it stage shift Ambition: Increase 5ys and 10ys – with 57% surviving 10+ years Increase 1ys to 75% with reduction of variation
94
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Save thousands more lives: Spearhead a radical upgrade in prevention Drive a national ambition to achieve earlier diagnosis, and with it stage shift “If the taskforce recommendations are implemented 30,000 cancer deaths a year could be saved by 2020, of these 11,000 will be through early diagnosis”
95
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Save thousands more lives: Spearhead a radical upgrade in prevention Drive a national ambition to achieve earlier diagnosis, and with it stage shift “If the taskforce recommendations are implemented 30,000 cancer deaths a year could be saved by 2020, of these 11,000 will be through early diagnosis”
96
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Early Diagnosis Implement NICE Guidance (NG12) Invest in diagnostic capacity Direct access to diagnostic capacity Enhance screening uptake 28 days to diagnosis (to replace 2WW) Education – Undergraduate, postgraduate, CPD
97
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Save thousands more lives Transform patient experience and quality of life
98
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Save thousands more lives Transform patient experience and quality of life Patient experience to be given as high a priority as clinical effectiveness and safety Transform approach to support those living with and beyond cancer Continuous improvement in patient experience, with reduction in variation Continuous improvement in long-term quality of life
99
RCGP and Cancer Research UK Workshop
Cancer Strategy has three core aims: Save thousands more lives Transform patient experience and quality of life Invest now to save later
100
RCGP and Cancer Research UK Workshop
101
RCGP and Cancer Research UK Workshop
Prevention Tobacco Food Immunisations Exercise Environment Early detection Awareness Health care seeking Screening Access Diagnosis Investigations Access Technology Decision support Treatment Surgery Chemotherapy Radiotherapy Comorbidity Psychology Survivorship Follow-up Late effects Rehabilitation Health promotion End of life Basic palliation Specialised Social Bereavement
102
RCGP and Cancer Research UK Workshop
Prevention Tobacco Food Immunisations Exercise Environment Early detection Awareness Health care seeking Screening Access Diagnosis Investigations Access Technology Decision support Treatment Surgery Chemotherapy Radiotherapy Comorbidity Psychology Survivorship Follow-up Late effects Rehabilitation Health promotion End of life Basic palliation Specialised Social Bereavement Primary Care could (should?) have a part to play throughout the cancer pathway, and is well placed to do so…
103
RCGP and Cancer Research UK Workshop
Prevention Tobacco Food Immunisations Exercise Environment Early detection Awareness Health care seeking Screening Access Diagnosis Investigations Access Technology Decision support Treatment Surgery Chemotherapy Radiotherapy Comorbidity Psychology Survivorship Follow-up Late effects Rehabilitation Health promotion End of life Basic palliation Specialised Social Bereavement Primary Care could (should?) have a part to play throughout the cancer pathway, and is well placed to do so…if adequately resourced…
104
RCGP and Cancer Research UK Workshop
The Lancet Oncology: “The expanding role of Primary Care in Cancer Control” “For a long time, the role of primary care in cancer was largely seen a peripheral, but as prevention, diagnosis, survivorship, and end-of-life care assume greater importance in cancer policy, the defining characteristics of primary care become more important” The Lancet Oncology, Vol. 16, No. 12
105
RCGP and Cancer Research UK Workshop
The Lancet Oncology: “The expanding role of Primary Care in Cancer Control” “The strengths of primary care—its continuous, coordinated, and comprehensive care for individuals and families—are particularly evident in prevention and diagnosis, in shared follow-up and survivorship care, and in end-of-life care. ” The Lancet Oncology, Vol. 16, No. 12
106
RCGP and Cancer Research UK Workshop
The Lancet Oncology: “The expanding role of Primary Care in Cancer Control” “recommendations should be implemented by all stakeholders involved in cancer care…work should start now to ensure that patients get the optimum care to prevent, receive a diagnosis of, and survive cancer, and the best possible care should they die from the disease” The Lancet Oncology, Vol. 16, No. 12
107
RCGP and Cancer Research UK Workshop
Value in investing in early diagnosis:
108
RCGP and Cancer Research UK Workshop
Value in investing in early diagnosis: Why? To address our lowly cancer outcomes rank How? To lower threshold/readiness to refer with consistency When? Now
109
RCGP and Cancer Research UK Workshop
Value in investing in early diagnosis: Results?
110
RCGP and Cancer Research UK Workshop
Value in investing in early diagnosis: Results? Better medicine – earlier diagnosis (not just of cancer) Fewer consultations Better outcomes Less complaints/litigation Less £££
111
RCGP and Cancer Research UK Workshop
Living with and beyond cancer:
112
RCGP and Cancer Research UK Workshop
Living with and beyond cancer: Rising cancer incidence Falling cancer mortality
113
RCGP and Cancer Research UK Workshop
Living with and beyond cancer: Projections of cancer prevalence in the United Kingdom, 2010–2040 J Maddams, M Utley and H Møller
114
RCGP and Cancer Research UK Workshop
Survivorship:
115
RCGP and Cancer Research UK Workshop
Survivorship: Problems faced by cancer survivors: Physical Psychological Social Financial
116
RCGP and Cancer Research UK Workshop
Survivorship: Problems faced by cancer survivors: Physical Consequences of treatment Immediate (eg radiation proctitis) Late (eg ↑ x5 incidence of congestive heart failure after radiotherapy or chemotherapy for NHL) 10+ years after treatment
117
RCGP and Cancer Research UK Workshop
Survivorship: Problems faced by cancer survivors: Physical Consequences of treatment
118
RCGP and Cancer Research UK Workshop
Survivorship: Problems faced by cancer survivors: Physical Consequences of treatment
119
RCGP and Cancer Research UK Workshop
Survivorship: Problems faced by cancer survivors: Physical Consequences of treatment
120
RCGP and Cancer Research UK Workshop
Survivorship: Problems faced by cancer survivors: Physical Co-morbidities Living with other long-term conditions as well as cancer reduces people’s chance of survival and increases their level of support needs. It also increases the cost of treatment1. 1. Macmillan Cancer Support. Routes from Diagnosis research programme. Unpublished data.
121
RCGP and Cancer Research UK Workshop
Survivorship: Problems faced by cancer survivors: Physical Co-morbidities Proportion of people with cancer living with one or more other long-term health conditions, by age group
122
RCGP and Cancer Research UK Workshop
Risk factors common to other long term conditions:
123
RCGP and Cancer Research UK Workshop
Risk factors common to other long term conditions: Aging population Lifestyles less healthy: Smoking Diet Alcohol Exercise Sun exposure
124
RCGP and Cancer Research UK Workshop
Risk factors common to other long term conditions: Aging population Lifestyles less healthy: Smoking Diet Alcohol Exercise Sun exposure Hypertension Heart disease Stroke Diabetes Dementia Mental Health Problems…
125
RCGP and Cancer Research UK Workshop
Problems faced by cancer survivors: Physical Recurrence
126
RCGP and Cancer Research UK Workshop
Problems faced by cancer survivors: Physical Recurrence – can be reduced
127
RCGP and Cancer Research UK Workshop
Problems faced by cancer survivors: Physical Recurrence – can be reduced Smoking Diet Alcohol Exercise Sun exposure
128
RCGP and Cancer Research UK Workshop
Problems faced by cancer survivors: Second (and third…) cancers.
129
RCGP and Cancer Research UK Workshop
Problems faced by cancer survivors: Second (and third…) cancers.
130
RCGP and Cancer Research UK Workshop
Problems faced by cancer survivors: Second (and third…) cancers. Of the 1.6 million people expected to be diagnosed with cancer this year in the U.S., about one in six will have already survived a different cancer before being developing this new one, according to statistics from the National Cancer Institute (NCI). Paraphrased from:
131
RCGP and Cancer Research UK Workshop
Second (and third…) cancers. Many preventable (c 40%): Smoking Diet Alcohol Exercise Sun exposure
132
RCGP and Cancer Research UK Workshop
Problems faced by cancer survivors: Physical Psychological 21% of patients living beyond cancer had MH problems Consequences of treatment – 10% develop major depression1. Pre-existing 1. Walker, J., et al., Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. The Lancet Psychiatry, (5): p
133
RCGP and Cancer Research UK Workshop
Problems faced by cancer survivors: Physical Psychological Social Consequences of treatment – impact on family and communities. Pre-existing – deprivation gradient
134
RCGP and Cancer Research UK Workshop
(last accessed )
135
RCGP and Cancer Research UK Workshop
Problems faced by cancer survivors: Physical Psychological Social Financial Consequences of treatment Loss of job/overtime for patient and carer
136
RCGP and Cancer Research UK Workshop
Survivorship - Exercise
137
RCGP and Cancer Research UK Workshop
Survivorship - Exercise Role of cancer rehab: Helps short term: Fatigue, stress, depression, quality of life Helps long term: Breast cancer patients 150 mins of exercise per week % cancer mortality Bowel cancer 6 hours of exercise per week % cancer mortality Prostate cancer 3 hours of exercise per week % cancer mortality Holmes, MD et al. Physical activity andsurvival after breast cancer diagnosis. JAMA.25 May (20):2479–86. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol :3527–3534. Kenfield SA, Stampfer MJ, Giovannucci, E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-upstudy. J Clin Oncol :726–732.
138
RCGP and Cancer Research UK Workshop
Survivorship - Exercise (last accessed )
139
RCGP and Cancer Research UK Workshop
(last accessed )
140
RCGP and Cancer Research UK Workshop
As survivorship increases: Co-morbidity Second cancers: previous history cancer risk other cancer E.g: Bowel: risk of prostate cancer by 32% Complication of treatment: E.g: pelvic radiation
141
RCGP and Cancer Research UK Workshop
End of Life Care
142
RCGP and Cancer Research UK Workshop
End of Life Care Palliative Care increasingly seen as “non-curative treatment and support”
143
RCGP and Cancer Research UK Workshop
End of Life Care
144
RCGP and Cancer Research UK Workshop
End of Life Care (last accessed )
145
RCGP and Cancer Research UK Workshop
End of Life Care A third of those diagnosed with cancer will die form their disease Most express preference to die at home
146
RCGP and Cancer Research UK Workshop
Dying at home (last accessed )
147
RCGP and Cancer Research UK Workshop
Dying at home (last accessed )
148
RCGP and Cancer Research UK Workshop
What’s new?
149
RCGP and Cancer Research UK Workshop
What’s new? Output from the National Cancer Transformation Board Delivery infrastructure: National Cancer Vanguard and Cancer Alliances Faster Diagnosis Standard: 28 days to diagnosis - being piloted currently Cancer Dashboard: single, integrated Cancer Dashboard
150
RCGP and Cancer Research UK Workshop
Alliances and Vanguards:
151
RCGP and Cancer Research UK Workshop
152
RCGP and Cancer Research UK Workshop
National Cancer Diagnosis Audit
153
RCGP and Cancer Research UK Workshop
National Cancer Diagnosis Audit Primary and secondary care data for patients diagnosed with cancer in 2014 England: 439 GP practices took part 17,043 (5.74%) patient pathways to cancer diagnosis Participating practices provided with a tailored report on their data to help highlight good practice and identify areas for quality improvement National results of the England audit have been published in the BJGP
154
RCGP and Cancer Research UK Workshop
National Cancer Diagnosis Audit
155
RCGP and Cancer Research UK Workshop
National Cancer Diagnosis Audit
156
RCGP and Cancer Research UK Workshop
National Cancer Diagnosis Audit Consultations prior to referral (where recorded) Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
157
RCGP and Cancer Research UK Workshop
National Cancer Diagnosis Audit The audit will be repeated (data collection to start in 2019)
158
RCGP and Cancer Research UK Workshop
“Non-communicable diseases are a slow-motion disaster; these are the diseases that break the bank”. Dr. Margaret Chan, Former Director-General of WHO
159
RCGP and Cancer Research UK Workshop
Key to cancer
160
RCGP and Cancer Research UK Workshop
Key to cancer Education
161
RCGP and Cancer Research UK Workshop
Key to cancer Education – public Education – patients Education – profession
162
RCGP and Cancer Research UK Workshop
Key to cancer Education – public Education – patients Education – profession Education – policy makers
163
RCGP and Cancer Research UK Workshop
Key to cancer Education – public Education – patients Education – profession Education – policy makers Education – politicians
164
RCGP and Cancer Research UK Workshop
Insanity:
165
RCGP and Cancer Research UK Workshop
Insanity: doing the same thing over and over again and expecting different results
166
RCGP and Cancer Research UK Workshop
Insanity: doing the same thing over and over again and expecting different results Albert Einstein
167
RCGP and Cancer Research UK Workshop
Our common goal?
168
RCGP and Cancer Research UK Workshop
Our common goal?
169
RCGP and Cancer Research UK Workshop
Our common goal? We are doing amazingly,
170
RCGP and Cancer Research UK Workshop
Our common goal? We are doing amazingly, but if resourced we can do even better, and match the best health care systems…
171
RCGP and Cancer Research UK Workshop
Our common goal? We are doing amazingly, but if resourced we can do even better, and match the best health care systems… As a wider health community we could do so much more …if resourced properly: We need to spend money now… to save money (and misery) later
172
RCGP and Cancer Research UK Workshop Primary Care and Cancer Control
Cancer: why all the interest? Why is early diagnosis important? Past – where were we? Present – where are we? Future – where next? Survivorship End of life care
173
RCGP and Cancer Research UK Workshop
One person can make a difference, and everyone should try.
174
RCGP and Cancer Research UK Workshop
One person can make a difference, and everyone should try. John F Kennedy
175
RCGP and Cancer Research UK Workshop
Thank you
176
RCGP and Cancer Research UK Workshop
Any questions?
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.